These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 15023402)

  • 1. Tumor immunology at the service of cancer immunotherapy.
    Finn OJ
    Curr Opin Immunol; 2004 Apr; 16(2):127-9. PubMed ID: 15023402
    [No Abstract]   [Full Text] [Related]  

  • 2. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
    Jäger E; Jäger D; Knuth A
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell epitope peptide vaccines.
    Elsawa SF; Rodeberg DA; Celis E
    Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D; Jäger E; Bert F; Knuth A
    Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
    [No Abstract]   [Full Text] [Related]  

  • 6. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor vaccine: current trends in antigen specific immunotherapy.
    Baral R
    Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Fry TJ; Lankester AC
    Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-testis antigens: targets for cancer immunotherapy.
    Chen YT; Old LJ
    Cancer J Sci Am; 1999; 5(1):16-7. PubMed ID: 10188055
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular mechanisms of tumor and immune system interaction].
    Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS
    Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer vaccine development: on the way to break immune tolerance to malignant cells.
    Mocellin S; Rossi CR; Nitti D
    Exp Cell Res; 2004 Oct; 299(2):267-78. PubMed ID: 15350526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer vaccines: pessimism in check.
    Mocellin S; Mandruzzato S; Bronte V; Marincola FM
    Nat Med; 2004 Dec; 10(12):1278-9; author reply 1279-80. PubMed ID: 15580242
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer immunotherapy targeting the telomerase reverse transcriptase.
    Huo LF; Tang JW; Huang JJ; Huang PT; Huang CF; Kung HF; Lin MC
    Cell Mol Immunol; 2006 Feb; 3(1):1-11. PubMed ID: 16549043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigens for cancer immunotherapy.
    Neller MA; López JA; Schmidt CW
    Semin Immunol; 2008 Oct; 20(5):286-95. PubMed ID: 18951039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer vaccines and immunotherapies: emerging perspectives.
    Henderson RA; Mossman S; Nairn N; Cheever MA
    Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges for cancer vaccine development.
    Tabi Z; Man S
    Adv Drug Deliv Rev; 2006 Oct; 58(8):902-15. PubMed ID: 16979786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology and breast cancer: therapeutic cancer vaccines.
    Curigliano G; Rescigno M; Goldhirsch A
    Breast; 2007 Dec; 16 Suppl 2():S20-6. PubMed ID: 17706425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy].
    Van den Eynde B
    Bull Mem Acad R Med Belg; 2007; 162(5-6):352-6. PubMed ID: 18405005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor escape from the immune response: a major hurdle for successful immunotherapy of cancer?
    Chouaib S
    Tunis Med; 2005 Dec; 83 Suppl 12():7-10. PubMed ID: 16430055
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Fry TJ; Lankester AC
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):109-27. PubMed ID: 20113898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.